IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bellevue Asset Management AG

Portfolio Profile

CIK: 0001642343 | Kuesnacht, V8

$57.6M
AUM
127
Positions
98.96%
Top 10 Conc.
99.4%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Biogen Inc.(BIIB)84,030$25.7M44.72%
2Boston Scientific Corporation(BSX)460,000$8.5M14.74%
3BioMarin Pharmaceutical Inc.(BMRN)65,000$6.8M11.83%
4Coherus BioSciences, Inc(CHRS)257,000$5.9M10.25%
5Agios Pharmaceuticals, Inc.(AGIO)54,000$3.5M6.09%
6Alnylam Pharmaceuticals Inc.(ALNY)24,000$2.3M3.92%
7Acadia Pharmaceuticals, Inc.(ACAD)45,000$1.6M2.79%
8AngioDynamics, Inc.(ANGO)100,000$1.2M2.11%
9Abbvie Inc.(ABBV)15,000$889.0K1.54%
10Arbutus Biopharm Corporation(ABUS)125,000$556.0K0.97%

Sector Allocation

Latest filing, equity positions only

Healthcare99.56% · $57.3M
Unclassified0.43% · $248.4K
Financial Services0.01% · $4.9K

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Unclassified0.5%0.43%-0.07%
Healthcare99.5%99.56%+0.06%

AUM History

$68.8M | 141 pos.
$72.2M | 139 pos.
$51.4M | 133 pos.
$57.6M | 127 pos.
Q1
15
Q2
15
Q3
15
Q4
15

Recent Activity

Financial Services0%0.01%+0.01%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

Cap SizePrev %Curr %Change
Large Cap72.29%75.68%+3.39%
Micro Cap8.97%10.26%+1.29%
Small Cap11.48%9.19%-2.29%
Mid Cap3.85%2.85%-1%
Mega Cap2.91%1.59%-1.32%
Unclassified0.5%0.43%-0.07%

Quarter-over-quarter position changes

9
New
15
Closed
39
Increased
25
Decreased
54
Unchanged